These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38074445)

  • 1. The path to a European Health Union.
    McKee M; de Ruijter A
    Lancet Reg Health Eur; 2024 Jan; 36():100794. PubMed ID: 38074445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies.
    Gontariuk M; Krafft T; Rehbock C; Townend D; Van der Auwermeulen L; Pilot E
    Front Public Health; 2021; 9():698995. PubMed ID: 34490183
    [No Abstract]   [Full Text] [Related]  

  • 3. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of Personalized Medicine landscape and policies in the European Union.
    Beccia F; Hoxhaj I; Castagna C; Strohäker T; Cadeddu C; Ricciardi W; Boccia S
    Eur J Public Health; 2022 Nov; 32(6):844-851. PubMed ID: 36305782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twentieth anniversary of the European Union health mandate: taking stock of perceived achievements, failures and missed opportunities - a qualitative study.
    Rosenkötter N; Clemens T; Sørensen K; Brand H
    BMC Public Health; 2013 Nov; 13():1074. PubMed ID: 24225055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The architecture of the European Union's pandemic preparedness and response policy framework.
    Eerens D; Hrzic R; Clemens T
    Eur J Public Health; 2023 Feb; 33(1):42-48. PubMed ID: 36399053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Union Directive on the application of patients' rights in cross-border healthcare. Could it be part of the Global Health Summit strategy?
    Santuari A
    Int J Risk Saf Med; 2022; 33(2):125-131. PubMed ID: 35147563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of citizens' subjective perception of safe antibiotic use in European Union countries.
    Zilinskas G; Tamasauskiene L; Tamasauskas D
    J Infect Public Health; 2019; 12(2):229-235. PubMed ID: 30389369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the European General Data Protection Regulation (GDPR) on Health Data Management in a European Union Candidate Country: A Case Study of Serbia.
    Marovic B; Curcin V
    JMIR Med Inform; 2020 Apr; 8(4):e14604. PubMed ID: 32301736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Union, economies and public health: not one without the other.
    Vervoort D; van Daalen KR
    Public Health; 2021 May; 194():1-3. PubMed ID: 33836317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novelties of the regulation on health technology assessment, a key achievement for the European union health policies.
    Pisapia A; Banfi G; Tomaiuolo R
    Clin Chem Lab Med; 2022 Jul; 60(8):1160-1163. PubMed ID: 35624072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating efficiency of Directive 2011/24/EU cross-border healthcare in member states.
    Ibrahim MD; Hocaoglu MB; Numan B; Daneshvar S
    J Comp Eff Res; 2018 Aug; 7(8):827-834. PubMed ID: 29770704
    [No Abstract]   [Full Text] [Related]  

  • 15. European decision-maker perspective with regard to influenza prevention policies.
    Lopalco PL
    J Prev Med Hyg; 2016; 57(1):E5-8. PubMed ID: 27346941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-border healthcare: A review and applicability to North America during COVID-19.
    Glass LT; Schlachta CM; Hawel JD; Elnahas AI; Alkhamesi NA
    Health Policy Open; 2022 Dec; 3():100064. PubMed ID: 35036910
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.